Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Dror Ortho-Design, Inc. publishes a filing, an earnings call transcript or a press release.

Get DROR alerts

About Chaim Hurvitz

Chaim Hurvitz is recorded as Board Member at Dror Ortho-Design, Inc. (DROR) since December 28, 2023, Chairman at Dror Ortho-Design, Inc. (DROR) and Board Member at NRX Pharmaceuticals, Inc. (NRXP). The newest filing on record that lists Chaim Hurvitz as Chairman at Dror Ortho-Design, Inc. (DROR) is dated December 18, 2023. The newest filing on record that lists Chaim Hurvitz as Board Member at NRX Pharmaceuticals, Inc. (NRXP) is dated February 23, 2026. NRX Pharmaceuticals, Inc. reported in an 8-K filed March 24, 2026 that Chaim Hurvitz was appointed Class I director, effective March 23, 2026. Dror Ortho-Design, Inc. reported in an 8-K filed January 4, 2024 that Chaim Hurvitz was appointed Director, effective December 28, 2023. Dror Ortho-Design, Inc. reported in an 8-K filed August 14, 2023 that Chaim Hurvitz was appointed Chairman of our board of directors, effective January 17, 2012. Equibles holds 5 filed executive changes naming Chaim Hurvitz; each is listed under recent activity with its source filing. Dror Ortho-Design, Inc. is classified in the Personal Services industry within the Consumer Cyclical sector. NRX Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Dror Ortho-Design, Inc. includes Eliyahu (Lee) Haddad (CEO and Board Member), Lee Haddad (CEO and Board Member), Moshe Shvets (CTO and Board Member) and 2 others.

“The Company's stockholders elected Chaim Hurvitz and Michael Taylor as Class I directors to serve until the 2028 annual meeting of stockholders and until such director's successor has been duly elected and qualified.”
NRX Pharmaceuticals, Inc. Form 8-K, filed March 24, 2026 · Read the filing
“Election of the five directors named in the Proxy Statement to the Board to serve until the annual meeting of stockholders in 2024 or until each one's respective successor has been duly elected and qualified.”
Dror Ortho-Design, Inc. Form 8-K, filed January 4, 2024 · Read the filing

Affiliation history

Company network

Current role

Personal Services · Consumer Cyclical

Chairman, Board Member

2023-12-28–present

Leadership on record at Dror Ortho-Design, Inc.

Leadership on record at NRX Pharmaceuticals, Inc.

Recent activity